Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

The Ohio State University

Status: Completed

Conditions: Tobacco-Related Carcinoma

Treatments: Other: Health communications

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05393869

K99CA260718 (U.S. NIH Grant/Contract)

NCI-2022-02543 (Registry Identifier)

OSU-20427

Details and patient eligibility

About

This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.

Full description

PRIMARY OBJECTIVES:

I. Identify absolute and relative risk anti-tobacco messages that effectively communicate polytobacco risks to lesbian, gay, bisexual, transgender (LGBT) young adults.

Participants view anti-tobacco messages and rate them for perceived effectiveness and reactance.

Enrollment: 2,849 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Young adults (age 18-35 years)
• Live in the United States

At least 50% of the sample also:

• Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

2,849 participants in 7 patient groups

AR-Quit

Experimental group

Description:

Participants view messages with absolute risk and quit statements

Treatment:

Other: Health communications

AR-Switch

Experimental group

Description:

Participants view messages with absolute risk and switch statements

Treatment:

Other: Health communications

AR-Combination

Experimental group

Description:

Participants view messages with absolute risk and combination quit+switch statements

Treatment:

Other: Health communications

RR-Quit

Experimental group

Description:

Participants view messages with comparative risk and quit statements

Treatment:

Other: Health communications

RR-Switch

Experimental group

Description:

Participants view messages with comparative risk and switch statements

Treatment:

Other: Health communications

RR-Combination

Experimental group

Description:

Participants view messages with comparative risk and combination quit+switch statements

Treatment:

Other: Health communications

Control

Other group

Description:

Participants view FDA regulatory messages

Treatment:

Other: Health communications